IP Library › Granted Patent US 7,888,069
Granted Patent B2
US 7,888,069 · App. 11/962,924 · Granted Feb 15, 2011

Plant-made west nile virus (WNV) vaccines, vectors and plant codon optimized sequences

Assignees: Dow Agrosciences LLC; The United States of America as represented by the Secretary of Argriculture
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,888,069
App. No.
11/962,924
Granted
Feb 15, 2011
Kind
B2
Abstract

The subject application provides various compositions of matter directed to West Nile virus (WNV) polypeptides and fragments thereof and polynucleotides, vectors and transformed host cells that encode, direct the expression of, or produce WNV polypeptides as set forth herein. Methods of using the polypeptides and polynucleotides for the production of immune responses in individuals or detecting the presence of WNV specific or neutralizing antibodies are also provided herein.

Claims (21)

1. An isolated polynucleotide comprising:

a) a sequence encoding a polypeptide comprising SEQ ID NO: 11 optionally wherein said polynucleotide sequence has a G+C content of at least 40% and less than 50%;

b) a genetic construct comprising a polynucleotide sequence as set forth in (a); or

c) a vector comprising a polynucleotide or genetic construct as set forth in (a) or (b).

2. The isolated polynucleotide according to claim 1 , wherein said polynucleotide comprises SEQ ID NO: 4 or 10.

3. The isolated polynucleotide according to claim 2 , wherein said polynucleotide comprises SEQ ID NO: 4.

4. The isolated polynucleotide according to claim 2 , wherein said polynucleotide comprises SEQ ID NO: 10.

5. A transgenic plant, plant cell, or plant part comprising a polynucleotide as set forth in claim 1 .

6. A method of making polypeptide comprising:

a) transforming a cell with a polynucleotide encoding SEQ ID NO: 11;

b) culturing said transformed cell under conditions that allow for the proliferation of said transformed plant cell and the accumulation of said polypeptide; and

c) recovering or purifying said at least one polypeptide from said cell.

7. The method according to claim 6 , wherein the cell is selected from the group consisting of a lower plant cell, a monocot plant cell, and a dicot plant cell, a prokaryotic cell and a mammalian cell line.

8. The method according to claim 7 , wherein the cell is a tobacco cell line.

9. The method according to claim 8 , wherein said tobacco cell line is NT-1.

10. A method of making polypeptide comprising:

a) transforming a cell with a polynucleotide comprising SEQ ID NO: 4 or 10;

b) culturing said transformed cell under conditions that allow for the proliferation of said transformed plant cell and the accumulation of said polypeptide; and

c) recovering or purifying said at least one polypeptide from said cell,

wherein said cell is a tobacco cell line.

11. The method according to claim 10 , wherein said tobacco cell line is NT-1.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2010
From: LETCHWORTH, GEOFFREY J.
To: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE
Reel/Frame 025163/0759 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2010
From: SMITH, KELLEY A.; WEBB, STEVEN R.; EVANS, STEVEN L.; MERLO, DONALD J.; MIHALIAK, CHARLES A.
To: DOW AGROSCIENCES LLC
Reel/Frame 025164/0013 →
Continuity (2)
Provisional Application 60871518 · Dec 22, 2006
Related Publication 20090069229A1 · Mar 12, 2009